Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075.
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose 5% provides a source of carbohydrates and calories to restore blood glucose levels and correct dehydration. Potassium chloride replenishes potassium ions, which are essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. The combination corrects hypokalemia and prevents potassium depletion during intravenous fluid therapy.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion: 500-1000 mL at a rate of 100-200 mL/hour, not exceeding 25 mEq potassium per hour (or 0.5 mEq/kg/hour) and a maximum concentration of 40 mEq/L. Total daily dose depends on fluid and electrolyte needs.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose: not applicable (endogenous); potassium: 12-24 hours (distribution half-life), terminal phase not defined due to homeostatic regulation.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Renal: Potassium excreted primarily via kidneys (90%) with some fecal loss; dextrose is metabolized to CO2 and water, excreted renally as water and bicarbonate (less than 5% unchanged).
Category C
Category C
IV Fluid
IV Fluid